Molecular Partners AG
Molecular Partners AG (MOLN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · MOLN · as of Sep 30, 2025
Ownership Breakdown
6
Institutional Holders
$13.29M
Total Inst. Value
▼ $425,632 vs Q2
37.51M
Shares Outstanding
freeFloat 99.72%
3.58M
13F Shares Held
▼ 4,746 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
MOLN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 6 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 2.22M | 5.94% | 5.94% | $8.24B | Nov 14, 2025 | — held |
BVF INC/IL biological products, (no diagnostic substances) | 1.35M | 3.62% | 3.62% | $5.02B | Nov 14, 2025 | — held |
UBS GROUP AG biological products, (no diagnostic substances) | 5.3K | 1.43% | 1.43% | $19.81M | Nov 13, 2025 | ▼ 4.9K |
MORGAN STANLEY biological products, (no diagnostic substances) | 367 | 0.10% | 0.10% | $1.36M | May 27, 2026 | — held |
BANK OF AMERICA CORP /DE/ biological products, (no diagnostic substances) | 157 | 0.04% | 0.04% | $582,000 | Feb 3, 2026 | — held |
EVERSOURCE WEALTH ADVISORS, LLC biological products, (no diagnostic substances) | 155 | 0.04% | 0.04% | $575,000 | Nov 10, 2025 | ▲ 114 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
1
Increased
+114 shares0
New Positions
first time holders1
Decreased
−4.9K shares0
Sold Out
fully exitedNet shares change (top 50)
4.7K
+114 / −4.9K
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
MOLN insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Molecular Partners AG (MOLN) is primarily owned by institutional investors, who hold approximately 9.6% of total shares outstanding. Company insiders own approximately 0.28%, while retail and public investors account for the remaining 90.17%.
The largest institutional shareholder of Molecular Partners AG is SUVRETTA CAPITAL MANAGEMENT, LLC, holding approximately 2.22 million shares — equal to 5.94% of outstanding shares — as of September 30, 2025.
A total of 6 institutional investors currently hold MOLN stock, with a combined institutional value of approximately $13,287,291 as of the most recent 13F filing period.
Frequently asked questions
MOLN ownershipMolecular Partners AG (MOLN) is primarily owned by institutional investors, who hold approximately 9.6% of shares. The largest shareholder is SUVRETTA CAPITAL MANAGEMENT, LLC with a 5.94% stake. Company insiders hold 0.28%. Data sourced from SEC Form 13F as of September 30, 2025.